CRISPR Therapeutics (CRSP) Tops Q4 EPS by 105c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. ADYEN:NA
8. ADYYF
9. TPR
10. DGNX

February 21, 2024 8:05 AM EST

CRISPR Therapeutics (NASDAQ: CRSP) reported Q4 EPS of $1.10, $1.05 better than the analyst estimate of $0.05.

For earnings history and earnings-related data on CRISPR Therapeutics (CRSP) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings